Abnormal expression of PERI circadian-clock gene in oral squamous cell carcinoma

OncoTargets and Therapy

Volumn 5, Issue , 2012, Pages 403-407

  Chen, Rui ^a   Yang, Kai ^a   Zhao, Ning Bo ^a   Zhao, Dan ^a   Chen, Dan ^a   Zhao, Chun Rong ^a   Tang, Hong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Circadian gene; Immunohistochemistry; Oral cancer; PERI; Real time reverse transcriptase polymerase chain reaction; Squamous cell

Indexed keywords

BETA ACTIN; LIOTHYRONINE; MESSENGER RNA; PER1 PROTEIN; THYROXINE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CANCER STAGING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PATHOPHYSIOLOGY; PERIOD 1 GENE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84873903414     PISSN: 11786930     EISSN: None     Source Type: Journal    
DOI: 10.2147/OTT.S38508     Document Type: Article

References (21)

1. Hara Y, Onishi Y, Oishi K, Miyazaki K, Fukamizu A, Ishida N. Molecular characterization of Mybbp1a as a co-repressor on the Period2 promoter. Nucleic Acids Res. 2009;37:1115-1126.
2. Badiu C. Genetic clock of biologic rhythms. J Cell Mol Med. 2003;7: 408-416.
3. Sahar S, Sassone-Corsi P. Metabolism and cancer: the circadian clock connection. Nat Rev Cancer. 2009;9:886-896.
4. Cao Q, Gery S, Dashti A, et al. A role for the clock gene per1 in prostate cancer. Cancer Res. 2009;69:619-7625.
5. Mostafaie N, Kállay E, Sauerzapf E, et al. Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer. Mol Carcinog. 2009;48:642-647.
6. Ye h KT, Yang MY, Liu TC, et al. Abnormal expression of period 1 (PER1) in endometrial carcinoma. J Pathol. 2005;206:111-120.
7. Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol. 2012;33:149-155.
8. Yang MY, Yang WC, Lin PM, et al. Altered expression of circadian clock genes in human chronic myeloid leukemia. J Biol Rhythms. 2011; 26:136-148.
9. Yang X, Wood PA, Ansell CM, et al. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int. 2009;26:1323-1339.
10. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffer HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell. 2006;22:375-382.
11. Sato F, Nagata C, Liu Y, et al. Period1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells. J Biochem. 2009;146:833-838.
12. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309-316.
13. Johnson NW, Warnakulasuriya S, Gupta PC, et al. Global oral health inequalities in incidence and outcomes for oral cancer causes and solutions. Adv Dent Res. 2011;23:237-246.
14. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumors, 7th ed. London, UK: Wiley; 2010.
15. Xu W, Wang LW, Shi JZ, Gong ZJ. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by concanavalin A in mice. Hepatobiliary Pancreat Dis Int. 2009;8:300-308.
16. Chen ST, Choo KB, Hou M F, et al. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis. 2005;26:1241-1246.
17. Murphy PJ, Campbell SS. Physiology of the circadian system in animals and humans. J Clin Neurophysiol. 1996;13:2-16.
18. Eismann EA, Lush E, Sephton SE. Circadian effects in cancer-relevant psychoneuroendocrine and immune pathways. Psychoneuroendocrinology. 2010;35:963-976.
19. Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59:828-851.
20. Chang L, Wang YH, Liu YY, et al. Key region of laminin receptor 1 for interaction with human period1. Afr J Biotechnol. 2010;9: 6401-6407.
21. Klein G, Vellenga E, Fraaije M W, Kamps WA, de Bont ES. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, eg, acute leukemia. Crit Rev Oncol Hematol. 2004;50:87-100.